Nirvana Life Sciences Inc. (CSE: NIRV)

Canada flag Canada · Delayed Price · Currency is CAD
0.0500
0.00 (0.00%)
Jan 20, 2025, 9:30 AM EST
100.00%
Market Cap 2.41M
Revenue (ttm) n/a
Net Income (ttm) -459.52K
Shares Out 48.23M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 950
Open 0.0500
Previous Close 0.0500
Day's Range 0.0500 - 0.0500
52-Week Range 0.0100 - 0.0800
Beta 0.80
RSI 38.57
Earnings Date Dec 31, 2024

About Nirvana Life Sciences

Nirvana Life Sciences Inc. engages in the research and development of therapeutic products to address addiction. The company is headquartered in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Bruce Clark
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol NIRV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.